Rather than the canonical role of p21 in the nucleus inhibiting cyclin-dependent kinase, CRL2LRR−1 mediates the degradation of cytoplasmic p21 and then limits cell motility in cancer cells.61 The gene discussed is CDKN1A; the disease is cancer.